TIMP-3 has proved beneficial in diseases characterized by enhanced proteolysis, including arthritis and cancer13,15; thus, approaches to increase its bioavailability in the tissue have been developed for the therapy of such diseases16,38,49. This evidence concerns the gene TIMP3 and Arthritis.